08:48:31 EDT Fri 29 Mar 2024
Enter Symbol
or Name
USA
CA



Breathtec Biomedical Inc
Symbol BTH
Shares Issued 38,082,698
Close 2017-09-21 C$ 0.115
Market Cap C$ 4,379,510
Recent Sedar Documents

BCSC asks judge to compel Tak to answer questions

2017-09-22 10:47 ET - Street Wire

See Street Wire (C-*BCSC) BC Securities Commission

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Mike Caswell

The B.C. Securities Commission is looking to question a Burnaby man about trading in two listings, Newgen Biopharma Corp. and Breathtec Biomedical Inc. The regulator says that it is investigating some unspecified activity with those companies and is looking closely at Vancouver brokerage Mackie Research Capital Corp. The investigation has led to the Burnaby man, who is named Harish Tak.

Details of the BCSC's investigation are contained in a petition that the regulator filed in the Supreme Court of British Columbia on Wednesday, Sept. 20. The petition seeks a court order that would compel Mr. Tak to answer questions from investigators. According to the BCSC, he has so far refused to do so.

It is far from clear what the BCSC intends to ask Mr. Tak, although it is no secret that one of the companies the BCSC mentioned, Newgen, is a regulatory target. The company, which trades on the OTC Markets, attracted a suspension from the U.S. Securities and Exchange Commission on March 28, 2017. The regulator said that there were questions about the identity of the company's major shareholder and about undisclosed control persons.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed